Nabriva Therapeutics plc - Ordinary Shares (NBRV): Price and Financial Metrics
Nabriva Therapeutics plc - Ordinary Shares (NBRV)
Today's Latest Price: $0.68 USD
0.00 (-0.09%)
Updated Jul 2 4:00pm
Add NBRV to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 214 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
NBRV Stock Summary
- NBRV's price/sales ratio is 78.77; that's higher than the P/S ratio of 97.1% of US stocks.
- With a year-over-year growth in debt of -69.2%, Nabriva Therapeutics plc's debt growth rate surpasses just 3.22% of about US stocks.
- As for revenue growth, note that NBRV's revenue has grown 124.97% over the past 12 months; that beats the revenue growth of 95.41% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Nabriva Therapeutics plc, a group of peers worth examining would be FLDM, OBLN, TUFN, KALA, and AVGR.
- Visit NBRV's SEC page to see the company's official filings. To visit the company's web site, go to www.nabriva.com.
NBRV Daily Price Range
NBRV 52-Week Price Range
NBRV Stock Price Chart Technical Analysis Charts
NBRV Price/Volume Stats
| Current price | $0.68 | 52-week high | $2.77 |
| Prev. close | $0.68 | 52-week low | $0.49 |
| Day low | $0.65 | Volume | 3,217,885 |
| Day high | $0.68 | Avg. volume | 4,223,048 |
| 50-day MA | $0.71 | Dividend yield | N/A |
| 200-day MA | $1.28 | Market Cap | 969.26M |
Nabriva Therapeutics plc - Ordinary Shares (NBRV) Company Bio
Nabriva is a clinical-stage biopharmaceutical company engaged in the research and development of novel antibiotics to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The company was founded in 2006 and is based in Wien, Austria.
Loading social stream, please wait...